Effect of ·OH scavenging action by non-SH-containing angiotensin converting enzyme inhibitor imidaprilat using microdialysis

Journal of Physiology Paris

Volumn 92, Issue 1, 1998, Pages 1-4

  Obata, Toshio ^a   Yamanaka, Yasumitsu ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

ACE inhibitor; Hydroxyl radical; Microdialysis; Salicylic acid

Indexed keywords

2,3 DIHYDROXYBENZOIC ACID; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRILAT; FERROUS ION; HYDROXYL RADICAL; IMIDAPRILAT; RINGER SOLUTION; SALICYLATE SODIUM; SALICYLIC ACID; SCAVENGER; THIOL GROUP; IMIDAZOLE DERIVATIVE; IMIDAZOLIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENCY; DRUG STRUCTURE; HEART MUSCLE; MALE; MICRODIALYSIS; NONHUMAN; RAT; SCAVENGING SYSTEM; ANIMAL; CHEMICAL STRUCTURE; WISTAR RAT;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ENALAPRILAT; FREE RADICAL SCAVENGERS; HYDROXYL RADICAL; IMIDAZOLES; IMIDAZOLIDINES; MALE; MICRODIALYSIS; MOLECULAR STRUCTURE; RATS; RATS, WISTAR;

EID: 0031987362     PISSN: 09284257     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-4257(98)80016-8     Document Type: Article

References (22)

1. [1] Bagchi B., Prasad R., Das D.K., Direct scavenging of free radicals by captopril, an angiotensin converting enzyme inhibitor, Biochem. Biophys. Res. Commun. 158 (1989) 52-57.
2. [2] Beckman J.S., Beckman T.W., Chen J., Marshall P.M., Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide, Proc. Natl. Acad. Sci, U.S.A. 87 (1990) 1621-1624.
3. [3] Bellet M., Sassano P., Guyenne T., Covol P., Mènard J., Converting-enzyme inhibition buffers the counter-regulatory response to acute administration of nicardipine, Br. J. Pharmacol. 24 (1987) 465-472.
4. [4] Ben-Shachar D., Youdim M.B.H., Intranigral iron injection induces behavioral and biochemical 'parkinsonism' in rats, J. Neurochem. 57 (1991) 2133-2135.
5. [5] Cao W., Carney J.M., Duchon A., Floyd R.A., Chevion M., Oxygen free radical involvement in ischemia and reperfusion injury to brain, Neurosci. Lett. 88 (1988) 233-238.
6. [6] Das D.K., Engelman R.M., Rousou J.A., Breyer R.H., Otani H., Lemeshow S., Pathophysiology of superoxide radical as potential mediator of reperfusion injury in pig heart, Basic Res. Cardiol. 81 (1986) 155-166.
7. [7] Das D.K., George A., Liu X., Rao P.S., Detection of hydroxyl radical in the mitochondria of ischemic-reperfused myocardium by trapping with salicylate, Biochem. Biophys. Res. Commun. 165 (1989) 1004-1009.
8. [8] Floyd R.A., Watson J.J., Wong P.K., Sensitive assay of hydroxyl free radical formation utilizing high pressure liquid chromatography with electrochemical detection of phenol and salicylate hydroxylation products, J. Biochem. Biophys. Methods 10 (1984) 221-235.
9. [9] Halliwell B., Oxidants and the central nervous system: some fundamental questions. Is oxidant damage relevant to Parkinson's disease, Alzheimer's disease, traumatic injury, or stroke?, Acta Neurol. Scand. 126 (1989) 23-33.
10. [10] Halliwell B., Gutteridge J.M., Oxygen toxicity, oxygen radicals, transition metals and disease, Biochem. J. 219 (1984) 1-14.
11. [11] Halliwell B., Kaur H., Ingleman-Sundberg M., Hydroxylation of salicylate as an assay for hydroxyl radicals: a cautionary note, Free Rad. Biol. Med. 10 (1991) 439-441.
12. [12] Juggi J.S., Koenig-Berard E., van Gilst W.H., Cardioprotection by angiotensin-converting enzyme (ACE) inhibitors, Can. J. Cardiol. 9 (1993) 336-352.
13. [13] McCord J.M., Oxygen-derived free radicals in postischemic tissue injury, N. Engl. J. Med. 312 (1985) 159-163.
14. [14] Obata T., Hosokawa H., Yamanaka Y., In vivo monitoring of norepinephrine and hydroxyl radical generation on myocardial ischemic injury by dialysis technique, Am. J. Physiol. 266 (1994) 903-908.
15. [15] Obata T., Yamanaka Y., Cardiac microdialysis of salicylic acid ·OH generation on nonenzymatic oxidation by norepinephrine in rat heart, Biochem. Pharmacol. 53 (1997) 1375-1378.
16. [16] Obata T., Yamanaka Y, Chiueh C.C., In vivo release of dopamine by perfusion of 1-methyl-4-phenylpyridinium ion in the striatum with a microdialysis technique, Jpn. J. Pharmacol. 60 (1992) 311-313.
17. [17] Pou S., Cohen M.S., Britigan B.E., Rosen G.M., Spin-trapping and human neutrophils: limits of detection of hydroxyl radical, J. Biol. Chem. 264 (1989) 12299-12302.
18. [18] Powell S.R., Hall D., Use of salicylate as a possible probe for ·OH formation in isolated ischemic rat hearts, Free Rad. Biol. Med. 9 (1990) 133-141.
19. [19] Radzik D.M., Roston D.A., Kissenger P.T., Determination of hydroxylated aromatic compounds produced in a superoxide-dependent formation of hydroxyl radicals by liquid chromatography/electrochemistry. Anal. Biochem. 131 (1983) 458-464.
20. [20] Suzuki S., Sato H., Shimada H., Takashima N., Arakawa M., Comparative free radical scavenging action of angiotensin-converting enzyme inhibitors with and without the sulfhydryl radical, Pharmacology 47 (1993) 61-65.
21. 1-antagonists on bronchial reactivity and the cough reflex in man, Eur. J. Clin. Pharmacol. 37 (1989) 467-470.
22. [22] Yamanaka K., Takehara N., Murata K., Banno K., Sato T., Steady-state pharmacokinetics and pharmacodynamics of imidaprilat, an active metabolite of imidapril, a new angiotensin-converting enzyme inhibitor in spontaneously hypertensive rats, J. Pharmacol. Sci. 85 (1996) 1234-1237.